Intact (IgG class) rabbit anti-immunoglobulin antibodies are not mitogenic for mouse B cells but inhibit proliferation induced by F(ab')2 anti-Fab fragment antibodies (anti-Ig). In addition, cross-linkage of Fc and surface immunoglobulin receptors on B cells by intact anti-Ig inhibits inositol phospholipid breakdown (but not Ca2+ flux) resulting from ligation of antigen receptors. This system, therefore, provides a polyclonal model for B-cell inactivation by antigen-antibody complexes. T-cell-derived B-cell-stimulatory factor 1 acts syn. ergistically with submitogenic concentrations of F(ab')2 anti-Ig to induce B-cell proliferation. We show here that B-cellstimulatory factor 1 and intact anti-Ig also induce B cells to synthesize DNA. However, B-cell-stimulatory factor 1 does not induce inositol phospholipid breakdown, does not mobilize Ca2+ in B cells, nor does it influence the magnitude of these responses provoked by intact anti-Ig.
Murine B lymphocytes carry Fc receptors (FcR), which bind complexed IgG antibodies (1) . There is considerable evidence that these receptors deliver inhibitory signals that control B-cell activation, in particular, in feedback inhibition of antibody responses by IgG antibodies: low concentrations of the intact antibodies are much more immunosuppressive than their F(ab')2 counterparts (2) . Similarly, immunosuppression by anti-idiotypic IgG antibodies has been shown to be Fc dependent (3) .
These inhibitory effects of specific antigen-antibody complexes can be mimicked by intact (IgG class) rabbit antiimmunoglobulin antibodies, which interact with both surface immunoglobulin (sIg) and FcR on murine B cells (4) . F(ab')2 fragments of rabbit anti-immunoglobulin antibodies induce polyclonal activation of essentially all resting B cells, and high concentrations stimulate a substantial proportion of them to synthesize DNA (4, 5) . In marked contrast, the intact antibodies are not mitogenic but, instead, inhibit DNA synthesis induced by the F(ab')2 fragments (6) (7) (8) . This reflects their capacity to cocross-link sIg and FcR. As a result, a powerful dominant negative signal is delivered via the FcR that aborts B-cell activation (9) and second-messenger generation by sIg receptors, as measured by the breakdown of phosphatidylinositol bisphosphate (PtdInsP2) (10) .
Earlier work had shown that Fc-dependent suppression of antigen-specific B-cell responses can be overcome by T cells or T-cell-derived lymphokines-so-called T-cell-replacing factor(s) (11) (12) (13) -but the precise nature of the lymphokines responsible for this effect was not established. Extensive studies have now defined a number of lymphokines that participate in various phases of B-cell stimulation. One of these, B-cell-stimulatory factor 1 (BSF-1) acts on resting B cells and by itself induces these cells to enter a transitional activated state, characterized by the expression of high levels of Ia antigens (14, 15) . BSF-1 stimulates B cells cultured with submitogenic concentrations of anti-immunoglobulin antibodies to synthesize DNA (16) . We now show that BSF-1 also synergizes with intact anti-Fab fragment antibodies (anti-Ig) to induce B cells to proliferate. In contrast B-cell growth factor type II (BCGF-II), which has now been shown to be identical to T-cell-replacing factor (17, 18) , has no effect in this system.
MATERIALS AND METHODS
Mice. Three-to six-month-old male (CBA x C57BL/6)F1 mice, bred under specific-pathogen-free conditions at the National Institute for Medical Research (London) were used.
Reagents. The preparation of affinity-purified intact IgG, RF(ab')2, and Fab fragments of rabbit anti-mouse Fab antibodies (henceforth called anti-Ig) has been described (9 Preparation of B Cells. These were prepared from spleens as described elsewhere (9, 19) . Small, dense B cells were taken from the 85%/75% interface of two consecutive discontinuous Percoll (Pharmacia) density gradients (20) . In some experiments, they were additionally filtered through Sephadex G-10 to remove adherent cells (9) . For biochemical analyses, B cells were taken from the 85%/65% interface of Percoll density gradients and routinely filtered through Sephadex G-10 (9). The latter preparations contained >90% sIg-positive cells.
Lymphokine Preparations. Conditioned medium (CM-T2), from an alloreactive T-cell clone NIMP-T2 (21), was used in most experiments. This contains high titers of BSF-1 and BCGF-II and low levels of interleukins 2 and 3. Additional experiments were performed using highly purified (22) preparations of BSF-1, kindly provided by J. Ohara and W. E. Paul (National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD), or recombinant BSF-1 (23) donated by M. J. Howard (DNAX Research Institute, Palo Alto, CA). Partially purified BCGF-II was from the conditioned medium of a T-cell hybrid NIMP-TH1, which produces no other detectable lymphokines (21, 24) . A unit of BSF-1 is defined as the dilution of factor required to give half-maximal DNA synthesis with submitogenic doses of the F(ab')2 fragment of anti-Ig (22) . Similarly, a unit of BCGF-II is the dilution of factor required to give halfmaximal proliferation of the BCL, lymphoma (25 bovine serum albumin at 4°C. They were stained with acridine orange and ethidium bromide to final concentrations of 15 ,uM and 3 ,uM, respectively (28, 29) , and analyzed on a Cytofluorograph system 50H (Ortho Diagnostic Systems, Westwood, MA). The excitation wavelength has 488 nm with collection of green fluorescence at 530-565 nm and red fluorescence at >640 nm (29, 30) . RESULTS T-Cell Factor(s) Act Synergisticaily with the F(ab')2 Fragment of Anti-Ig and Intact Anti-Ig. High concentrations of the bivalent F(ab')2 fragment of anti-Ig, but not the monomeric Fab fragment or the intact IgG of anti-Ig, induce significant levels of DNA synthesis in mouse B cells (Fig. 1) . Furthermore, CM-T2, which contains BSF-1, markedly potentiated the response to submitogenic concentrations of F(ab')2 antiIg (Fig. 1A ). More importantly, B cells cultured with intact anti-Ig plus CM-T2 also showed substantial levels of DNA synthesis (Fig. 1B) .
These results, therefore, indicate that one or more T-cellderived lymphokines enable the nonmitogenic intact form of anti-Ig to induce B-cell proliferation. However, these factor(s) do not overcome the requirement for sIg cross-linking, since CM-T2 did not act synergistically with Fab fragments of anti-Ig (Fig. 1C) . The results in Fig. 1 [3H]Thymidine uptake was determined on day 3. Results are means ± SEM of triplicate cultures.
Purified BSF-1 Acts Synergistically with Both F(ab')2 and Intact Anti-Ig. Since CM-T2 contains both BSF-1 and BCGF-II, we next tested the capacity of the purified factors to induce proliferation with anti-Ig. Fig. 2A , the CM-T2 was added at different ,Ag/ml) or the F(ab')2 fragment of anti-Ig (6.6 ,ug/ml). In experiment 2, B cells were cultured with CM-T2 (same concentration), with recombinant BSF-1, or with semipurified BCGF-II and with intact lgG anti-Ig (10 ,ug/ml) or the F(ab')2 fragment of anti-Ig (6.6 jig/ml).
[3H]Thymidine uptakes were measured after 72 hr in culture and are means ± SEM of triplicate cultures.
times after initiation of the incubation with antibody, while in Earlier work had shown that T cells or T-cell replacing factor(s) can reverse Fc-dependent IgG antibody feedback (11) (12) (13) . Since BSF-1 can substantially reverse the Fcdependent inhibitory effects of anti-Ig, it now remains to be established if this factor can similarly influence Fc-dependent feedback of specific antibody responses. The fact that BGCF-II (which does have T-cell-replacing factor activity; refs. 17 and 18) does not act synergistically with intact anti-Ig (Table  1) was predictable, since this lymphokine acts on preactivated B cells (21) . Indeed, preliminary experiments have shown that intact anti-Ig inhibits BCGF-II-induced DNA synthesis in large, naturally occurring B cells.
We have shown that intact anti-Ig induces abortive activation of resting B cells driving the cells into a transitional state (GiT), characterized by the expression of high levels of la antigens (9) . Unlike the F(ab')2 antibodies, the intact form provokes a short-lived breakdown of PtdInsP2 in B cells (10) that, however, appears to be sufficient to generate a normal (Fig. 4) . This suggests that BSF-1 does not decrease the numbers of FcR on B cells significantly, although this has not been studied directly. In addition, CM-T2 alone neither provoked detectable PtdInsP2 breakdown nor caused an increase in [Ca2>]j, and that, at least in the short term, the factor does not detectably affect signaling by way of sIg receptors (see also refs. 33 and 34) . Although the mechanisms whereby FcR inhibit B-cell activation remain to be elucidated, the simplest explanation of our present findings is that the low levels of PtdInsP2 breakdown provoked by intact anti-Ig are sufficient to provide the necessary costimulus for BSF-1-induced DNA synthesis. This is supported by studies on nonmitogenic anti-Ig monoclonal antibodies, some of which stimulate minimal PtdInsP2 hydrolysis and yet act synergistically and effectively with BSF-1 (K.P.R., unpublished data).
